Your browser doesn't support javascript.
loading
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma.
Cabiati, Manuela; Gaggini, Melania; DE Simone, Paolo; Basta, Giuseppina; Gastaldelli, Amalia; Del Ry, Silvia.
Affiliation
  • Cabiati M; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
  • Gaggini M; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
  • DE Simone P; Department of Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy.
  • Basta G; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
  • Gastaldelli A; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
  • Del Ry S; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy - delry@ifc.cnr.it.
Minerva Endocrinol (Torino) ; 46(3): 367-369, 2021 09.
Article in En | MEDLINE | ID: mdl-32623844

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / RANK Ligand / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Liver Neoplasms Limits: Humans Language: En Journal: Minerva Endocrinol (Torino) Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / RANK Ligand / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Liver Neoplasms Limits: Humans Language: En Journal: Minerva Endocrinol (Torino) Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Italia